Dementia Biomarkers Associated With Age, Sex, APOE ε4 Status

Follow Drugslib on

Medically reviewed by Carmen Pope, BPharm. Last updated on April 21, 2025.

By Elana Gotkine HealthDay Reporter

MONDAY, April 21, 2025 -- Dementia biomarkers -- phosphorylated tau (P-tau181), neurofilament light (NfL), and glial fibrillary acidic protein (GFAP) -- are associated with age, sex, and apolipoprotein E (APOE) ε4 status, according to a study published online April 16 in Neurology.

Hannah Stocker, M.D., from the German Cancer Research Center in Heidelberg, and colleagues examined the association of age, sex, APOE ε4 status, and menopause with dementia-related blood biomarker levels and the rate of change in community-dwelling adults during 11 years. Within a population-based cohort study, a nested case-control study was conducted. The nested study included 1,026 participants (1:1 for incident dementia during follow-up:without dementia during follow-up) aged 50 to 75 years at baseline who were followed for 17 years.

The researchers observed cross-sectional and longitudinal significant associations for age with all dementia-related biomarkers. Compared with P-tau181 levels, NfL and GFAP levels correlated more strongly with age at baseline. Significantly higher levels and rates of increase in GFAP were seen for women, while levels of NfL were higher among men, after adjusting for age and APOE ε4. There was a significant association seen for APOE ε4 status with baseline and longitudinal levels of P-tau181 and GFAP. After adjusting for age, sex, and APOE ε4, premenopausal status was significantly associated with higher GFAP levels.

"Gaining a better understanding of these biomarkers will help improve our ability to test for dementia in the future with simple blood tests," Stocker said in a statement. "Our research underscores the need to further explore these biomarkers, including during menopause, in the development of dementia."

One author disclosed ties to pharmaceutical companies; one author has study-related patents issued and pending.

Abstract/Full Text

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

Source: HealthDay

Posted : 2025-04-22 06:00

Read more

Disclaimer

Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Popular Keywords